ARTICLE | Company News
GenVec, Northwestern University deal
February 20, 2001 8:00 AM UTC
GNVC received an exclusive license from the university to pigment epithelium-derived factor ( PEDF) for all ocular gene therapy applications. GNVC is developing PEDF as a gene therapy product to preve...